Dyer, CB
17  Ergebnisse:
Personensuche X
?
1

Comparison of the histology and immunohistochemistry of vac..:

Aberdein, D ; Munday, JS ; Dyer, CB...
New Zealand Veterinary Journal.  55 (2007)  5 - p. 203-207 , 2007
 
?
2

Vaccination-site sarcomas in cats in New Zealand:

Aberdein, D ; Munday, JS ; Dyer, CB...
New Zealand Veterinary Journal.  55 (2007)  1 - p. 50-50 , 2007
 
?
3

A possible predisposition to dilated cardiomyopathy in Hunt..:

Munday, JS ; Dyer, CB ; Hartman, AC.
New Zealand Veterinary Journal.  54 (2006)  5 - p. 231-234 , 2006
 
?
4

Procalcitonin is not a reliable biomarker of bacterial coin..:

Relph, KA ; Russell, CD ; Fairfield, CJ...
https://eprints.whiterose.ac.uk/187366/1/ofac179.pdf.  , 2022
 
?
5

Acute kidney injury in patients hospitalized with COVID-19 ..:

Sullivan, MK ; Lees, JS ; Drake, TM...
https://eprints.whiterose.ac.uk/183501/1/Acute%20kidney%20injury%20in%20patients%20hospitalized%20with%20COVID-19%20from%20the%20ISARIC%20WHO%20CCP-UK%20Study%20a%20prospective,%20multicentre%20cohor.pdf.  , 2022
 
?
8

Changes in in-hospital mortality in the first wave of COVID..:

Docherty, AB ; Mulholland, RH ; Lone, NI...
https://eprints.whiterose.ac.uk/174433/1/1-s2.0-S2213260021001752-main.pdf.  , 2021
 
?
9

Importance of patient bed pathways and length of stay diffe..:

Leclerc, QJ ; Fuller, NM ; Keogh, RH...
https://eprints.whiterose.ac.uk/181504/1/Importance%20of%20patient%20bed%20pathways%20and%20length%20of%20stay%20differences%20in%20predicting%20COVID-19%20hospital%20bed%20occupancy%20in%20England.pdf.  , 2021
 
?
10

A prenylated dsRNA sensor protects against severe COVID-19:

Wickenhagen, A ; Sugrue, E ; Lytras, S...
https://eprints.whiterose.ac.uk/179044/1/A%20prenylated%20dsRNA%20sensor%20protects%20against%20severe%20COVID-19.pdf.  , 2021
 
?
11

Characterisation of in-hospital complications associated wi..:

Drake, TM ; Riad, AM ; Fairfield, CJ...
https://eprints.whiterose.ac.uk/176374/1/1-s2.0-S0140673621007996-main.pdf.  , 2021
 
?
12

Non-steroidal anti-inflammatory drug use and outcomes of CO..:

Drake, TM ; Fairfield, CJ ; Pius, R...
https://eprints.whiterose.ac.uk/174432/1/1-s2.0-S2665991321001041-main.pdf.  , 2021
 
?
13

Co-infections, secondary infections, and antimicrobial use ..:

Russell, CD ; Fairfield, CJ ; Drake, TM...
https://eprints.whiterose.ac.uk/175330/1/1-s2.0-S2666524721000902-main.pdf.  , 2021
 
?
14

Development and validation of the ISARIC 4C deterioration m..:

Gupta, RK ; Harrison, EM ; Ho, A...
https://eprints.whiterose.ac.uk/171389/1/1-s2.0-S2213260020305592-main.pdf.  , 2021
 
?
15

Outcome of hospitalization for COVID-19 in patients with in..:

Drake, TM ; Docherty, AB ; Harrison, EM...
https://eprints.whiterose.ac.uk/186765/1/rccm.202007-2794oc.pdf.  , 2020
 
1-15